CIK: 1898490 - Address: C/O Theravance Biopharma Us, Inc., 901 Gateway Blvd, South San Francisco, CA 94080
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/13/24 20:42
11/11/24
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsFarnum RhondaCAOSVP,CommS-369.000-4-1323D
7/12/24 18:15
7/10/24
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsFarnum RhondaCAOSVP,CommS-369.000-4-1336D
2/22/24 20:04
2/22/24
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsFarnum RhondaCAOSVP,CommS-118.710-10312D
11/22/23 18:07
11/21/23
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsFarnum RhondaCAOSVP,CommS-1410.290-10331D
8/24/23 18:05
8/22/23
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsFarnum RhondaCAOSVP,CommS-179.470-2-1341D
6/12/23 18:08
6/8/23
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsFarnum RhondaCAOSVP,CommS-2011.130-2-1353D
3/13/23 17:57
3/9/23
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsFarnum RhondaCAOSVP,CommS-4110.200-4-1360D
5/24/22 19:11
5/23/22
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsFarnum RhondaCAOSVP,CommS-108.930-10330D
3/2/22 19:08
2/28/22
TBPHTheravance Biopharma, Inc.E9HealthDrugPharmaceutical PreparationsFarnum RhondaCAOSVP,CommS-2410.160-2-1333D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact